No photo of Yvo Beer

Yvo de Beer

20142020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Validation of an analytical method using HPLC-MS/MS to quantify osimertinib in human plasma and supplementary stability results

van Veelen, A., van Geel, R., de Beer, Y., Dingemans, A-M., Stolk, L., Ter Heine, R., de Vries, F. & Croes, S., Apr 2020, In : Biomedical Chromatography. 34, 4, 9 p., e4771.

Research output: Contribution to journalArticleAcademicpeer-review

Clinical validation study of dried blood spot for determining everolimus concentration in patients with cancer

Willemsen, A. E. C. A. B., Knapen, L. M., de Beer, Y. M., Bruggemann, R. J. M., Croes, S., van Herpen, C. M. L. & van Erp, N. P., 1 Apr 2018, In : European Journal of Clinical Pharmacology. 74, 4, p. 465-471 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Development and validation of an analytical method using UPLC-MS/MS to quantify everolimus in dried blood spots in the oncology setting

Knapen, L. M., de Beer, Y., Bruggemann, R. J. M., Stolk, L. M., de Vries, F., Tjan-Heijnen, V. C. G., van Erp, N. P. & Croes, S., 5 Feb 2018, In : Journal of Pharmaceutical and Biomedical Analysis. 149, p. 106-113 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Correlation of toxicity and efficacy with pharmacokinetics (PK) of pegylated liposomal doxorubicin (PLD) (Caelyx(A (R)))

Boers-Sonderen, M. J., van Herpen, C. M. L., van der Graaf, W. T. A., Desar, I. M. E., Arens-van der Logt, M. G. W., de Beer, Y. M., Ottevanger, P. B. & van Erp, N. P., Sep 2014, In : Cancer Chemotherapy and Pharmacology. 74, 3, p. 457-463 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

3 Citations (Scopus)